Integumentary System |
Skin |
Control |
6 MG/ML |
5 |
41 |
41 |
17 |
1 |
Inflammation |
Mild, Diffuse, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Control, Epidermis |
17 MG/ML |
5 |
48 |
48 |
9 |
1 |
Hyperplasia |
Minimal, Diffuse |
Moribund Sacrifice |
Integumentary System |
Skin |
Control, Epidermis |
6 MG/ML |
5 |
41 |
41 |
17 |
1 |
Necrosis |
Moderate, Focal |
Terminal Sacrifice |
Integumentary System |
Skin |
Control, Epidermis |
17 MG/ML |
5 |
47 |
47 |
11 |
1 |
Necrosis |
Marked, Diffuse |
Moribund Sacrifice |
Integumentary System |
Skin |
Control, Epidermis |
17 MG/ML |
5 |
50 |
50 |
9 |
1 |
Necrosis |
Marked, Diffuse |
Moribund Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
2 MG/ML |
5 |
37 |
37 |
17 |
1 |
Hyperplasia |
Minimal, Diffuse |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
6 MG/ML |
5 |
41 |
41 |
17 |
1 |
Hyperplasia |
Moderate, Diffuse |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
6 MG/ML |
5 |
42 |
42 |
17 |
1 |
Hyperplasia |
Moderate, Diffuse |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
6 MG/ML |
5 |
43 |
43 |
17 |
1 |
Hyperplasia |
Moderate, Diffuse |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
6 MG/ML |
5 |
44 |
44 |
17 |
1 |
Hyperplasia |
Moderate, Diffuse |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
6 MG/ML |
5 |
45 |
45 |
17 |
1 |
Hyperplasia |
Moderate, Diffuse |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
17 MG/ML |
5 |
47 |
47 |
11 |
1 |
Hyperplasia |
Moderate, Focal |
Moribund Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
6 MG/ML |
5 |
42 |
42 |
17 |
1 |
Necrosis |
Minimal, Focal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
6 MG/ML |
5 |
45 |
45 |
17 |
1 |
Necrosis |
Mild, Focal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
17 MG/ML |
5 |
46 |
46 |
10 |
1 |
Necrosis |
Marked, Focal |
Moribund Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
17 MG/ML |
5 |
47 |
47 |
11 |
1 |
Necrosis |
Moderate, Focal |
Moribund Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
17 MG/ML |
5 |
48 |
48 |
9 |
1 |
Necrosis |
Marked, Diffuse |
Moribund Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
17 MG/ML |
5 |
49 |
49 |
9 |
1 |
Necrosis |
Marked, Diffuse |
Moribund Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
17 MG/ML |
5 |
50 |
50 |
9 |
1 |
Necrosis |
Marked, Diffuse |
Moribund Sacrifice |
Integumentary System |
Skin |
SOA |
6 MG/ML |
5 |
41 |
41 |
17 |
1 |
Inflammation |
Mild, Diffuse, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
6 MG/ML |
5 |
42 |
42 |
17 |
1 |
Inflammation |
Mild, Diffuse, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
6 MG/ML |
5 |
44 |
44 |
17 |
1 |
Inflammation |
Minimal, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
6 MG/ML |
5 |
45 |
45 |
17 |
1 |
Inflammation |
Mild, Diffuse, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
17 MG/ML |
5 |
47 |
47 |
11 |
1 |
Inflammation |
Mild, Diffuse, Chronic Active |
Moribund Sacrifice |